Lexaria Bioscience Corp (LEXX)

Lexaria Bioscience Corp (LEXX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.5M; returns 1 day +3.0%, 1 week +7.7%, 1 year -77.4%.

Lexaria Bioscience Corp. is a biotechnology company focused on the development and out-licensing of its proprietary drug delivery platform, DehydraTECH. The technology utilizes a patented chemical dehydration process to enhance the oral bioavailability, speed of onset, and brain penetration of lipophilic active pharmaceutical ingredients (APIs).

Groups LEXX belongs to

• Biotechnology
• Recent Reverse Splits
• Canada Companies
• GLP-1 Agonists
• Metabolic Disorders
• Pharmaceuticals
• Clinical Stage Biotech
• Life Sciences
• Weight Management
• Cardiovascular Therapies

LEXX financial model: income statement, cash flow and balance sheet